Anne Messing Joins as Chief Commercial Officer at OraSure
OraSure Technologies, Inc. (NASDAQ: OSUR) has enthusiastically announced the appointment of Anne Messing as their Chief Commercial Officer. With a focus on enhancing their position in the healthcare market, OraSure aims to bolster its commitment to providing quality diagnostic solutions.
Experience and Leadership in Healthcare
Ms. Messing comes to OraSure with over 25 years of rich experience in the healthcare landscape, particularly within life sciences and clinical laboratory services. Having demonstrated remarkable success in various leadership roles, she has a strong track record of orchestrating growth and cultivating high-performing sales teams. At OraSure, she will be at the helm of the Sales, Marketing, Strategic Alliances, and Product Management departments.
Strategic Initiatives to Drive Growth
Previously, Anne Messing served as the Vice President and General Manager at Becton Dickinson (BD) Biosciences, where her strategic initiatives significantly exceeded market benchmarks and contributed to substantial sales growth from existing products and successful new launches. Her depth of experience extends to other prestigious organizations such as Danaher, Quest Diagnostics, and Siemens Healthcare Diagnostics. Ms. Messing's early career was spent working in laboratories, where she excelled as a certified medical technologist before transitioning into management roles.
Vision for the Future at OraSure
Reflecting on her new role, Ms. Messing expressed her excitement to contribute to OraSure's vision for the future. “I'm thrilled to step into this transformative chapter with OTI, particularly as the company gears up for a series of impactful product launches. It’s an excellent opportunity to make a transformative difference in healthcare,” she shared. President and CEO of OTI, Carrie Eglinton Manner, echoed these sentiments, highlighting Ms. Messing's remarkable abilities to generate exceptional value for stakeholders.
About OraSure Technologies
OraSure Technologies, Inc. is dedicated to transforming health by providing actionable insights and connecting individuals with healthcare solutions. OTI enhances the quality and accessibility of healthcare through innovative diagnostic products and sample management systems. Their products cater to various sectors, including clinical laboratories, hospitals, and direct-to-consumer markets. This commitment to innovation positions OraSure as a leader in the development and delivery of rapid diagnostic tests for critical medical conditions.
Contact Information
For further inquiries, please reach out to:
Investor Contact:
Jason Plagman
Vice President, Investor Relations
Email: investorinfo@orasure.com
Media Contact:
Amy Koch
Director, Corporate Communications
Email: media@orasure.com
Frequently Asked Questions
Who is Anne Messing?
Anne Messing is the newly appointed Chief Commercial Officer at OraSure Technologies, bringing over 25 years of experience in the healthcare industry.
What will Anne Messing's role involve at OraSure?
She will oversee Sales, Marketing, Strategic Alliances, and Product Management, shaping OTI's product portfolio and driving growth.
What previous positions did Ms. Messing hold?
Prior to OraSure, she held leadership roles at Becton Dickinson and other notable healthcare companies, focusing on sales and marketing leadership.
What is OraSure Technologies known for?
OraSure is recognized for its innovative diagnostic tests and sample management solutions, enhancing healthcare access and quality.
How can I contact OraSure's investor or media relations?
You can reach investor relations at investorinfo@orasure.com and media relations at media@orasure.com.
